CERo Therapeutics Holdings, Inc. CERO
0.00 USD 0.00 (+0.00%)
As ofNov 20, 2026, 2:43 PM EST
0.0037 Day range 0.0043
0.003 52-week range 0.135
- YTD
- -94.48%
- 1 year
- -93.83%
Ownership
- Institutions 5.08%
- Insiders 55.4%
- Public and other holders 39.5%
Held by insiders 55.42%
Held by institutions 5.08%
Float held by institutions 11.39%
Institutions 21
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Arch Venture Management, Llc | 0.96% | 1,444,296 | 72.94K | Sep 29, 2024 |
| Avantax Planning Partners, Inc. | 0.91% | 1,361,130 | 68.74K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.10% | 157,445 | 7.95K | Sep 29, 2024 |
| Selkirk Management Llc | 0.08% | 121,040 | 6.11K | Sep 29, 2024 |
| HRT Financial LP | 0.05% | 79,562 | 4.02K | Sep 29, 2024 |
| Fifth Lane Capital, LP | 0.05% | 76,593 | 3.87K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.10% | 144,145 | 7.28K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ATWOOD BRIAN G | Director | Conversion of Exercise of derivative security | Sep 24, 2024 | 0 |
| EHRLICH CHRISTOPHER B | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 24, 2024 | 5,795,410 |
| LAPORTE KATHLEEN D | Director | Conversion of Exercise of derivative security | Sep 24, 2024 | 0 |
| SLOAN STUART M | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 24, 2024 | 0 |
| YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 12, 2024 | 0 |
